Prediction of genetic risk for metabolic syndrome



      The aim of the study was to identify gene polymorphisms that confer susceptibility to metabolic syndrome in order to allow reliable assessment of genetic risk for this condition.

      Methods and results

      The study population comprised 1788 unrelated Japanese individuals (1033 men, 755 women), including 1017 subjects with metabolic syndrome (634 men, 383 women) and 771 controls (399 men, 372 women). The genotypes for 158 polymorphisms of 133 candidate genes were determined with a method that combines the polymerase chain reaction and sequence-specific oligonucleotide probes with suspension array technology. Multivariable logistic regression analysis with adjustment for age, sex, and the prevalence of smoking revealed that the −1131T → C polymorphism of the apolipoprotein A–V gene (APOA5) was significantly associated with the prevalence of metabolic syndrome, with the C allele representing a risk factor for this condition. A stepwise forward selection procedure demonstrated that APOA5 genotype (CC + TC versus TT) significantly affected the prevalence of metabolic syndrome. The C allele of this polymorphism was associated with an increased serum concentration of triglycerides and a decreased concentration of HDL-cholesterol.


      Genotype for APOA5 may prove reliable for assessment of genetic risk for metabolic syndrome.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ford E.S.
        • Giles W.H.
        • Dietz W.H.
        Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey.
        JAMA. 2002; 287: 356-359
        • Park Y.-W.
        • Zhu S.
        • Palaniappan L.
        • et al.
        The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey.
        Arch Intern Med. 2003; 163: 427-436
        • DeFronzo R.A.
        • Ferrannini E.
        Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerotic cardiovascular disease.
        Diab Care. 1991; 14: 173-194
      1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Groop L.
        Genetics of the metabolic syndrome.
        Br J Nutr. 2000; 83: S39-S48
        • Kissebah A.H.
        • Sonnenberg G.E.
        • Myklebust J.
        • et al.
        Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.
        Proc Natl Acad Sci USA. 2000; 97: 14478-14483
        • Francke S.
        • Manraj M.
        • Lacquemant C.
        • et al.
        A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27.
        Hum Mol Genet. 2001; 10: 2751-2765
        • Langefeld C.D.
        • Wagenknecht L.E.
        • Rotter J.I.
        • et al.
        Linkage of the metabolic syndrome to 1q23–q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study.
        Diabetes. 2004; 53: 1170-1174
        • McCarthy J.J.
        • Meyer J.
        • Moliterno D.J.
        • et al.
        Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients.
        Hum Genet. 2003; 114: 87-98
        • Robitaille J.
        • Brouillette C.
        • Houde A.
        • et al.
        Association between the PPAR-alpha-L162V polymorphism and components of the metabolic syndrome.
        J Hum Genet. 2004; 49: 482-489
        • Meirhaeghe A.
        • Cottel D.
        • Amouyel P.
        • Dallongeville J.
        Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women.
        Diabetes. 2005; 54: 3043-3048
        • Sattar N.
        • Gaw A.
        • Scherbakova O.
        • et al.
        Metabolic syndrome with and without C-protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
        Circulation. 2003; 108: 414-419
        • Ridker P.M.
        • Buring J.E.
        • Cook N.R.
        • Rifai N.
        C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women.
        Circulation. 2003; 107: 391-397
        • Kanazawa M.
        • Yoshiike N.
        • Osaka T.
        • et al.
        Criteria and classification of obesity in Japan and Asia-Oceania.
        Asia Pac J Clin Nutr. 2002; 11: S732-S737
        • Itoh Y.
        • Mizuki N.
        • Shimada T.
        • et al.
        High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population.
        Immunogenetics. 2005; 57: 717-729
        • Nakai K.
        • Habano W.
        • Fujita T.
        • et al.
        Highly multiplexed genotyping of coronary artery disease-associated SNPs using MALDI-TOF mass spectrometry.
        Hum Mut. 2002; 20: 133-138
        • Churchill G.A.
        • Doerge R.W.
        Empirical threshold values for quantitative trait mapping.
        Genetics. 1994; 138: 963-971
        • Pennacchio L.A.
        • Olivier M.
        • Hubacek J.A.
        • et al.
        An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.
        Science. 2001; 294: 169-173
        • Groenendijk M.
        • Cantor R.M.
        • de Bruin T.W.
        • Dallinga-Thie G.M.
        The apoAI-CIII-AIV gene cluster.
        Atherosclerosis. 2001; 157: 1-11
        • van der Vliet H.N.
        • Schaap F.G.
        • Levels J.H.
        • et al.
        Adenoviral overexpression of apolipoprotein A–V reduces serum levels of triglycerides and cholesterol in mice.
        Biochem Biophys Res Commun. 2002; 295: 1156-1159
        • Nabika T.
        • Nasreen S.
        • Kobayashi S.
        • Masuda J.
        The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese.
        Atherosclerosis. 2002; 165: 201-204
        • Endo K.
        • Yanagi H.
        • Araki J.
        • et al.
        Association found between the promoter region polymorphism in the apolipoprotein A–V gene and the serum triglyceride level in Japanese schoolchildren.
        Hum Genet. 2002; 111: 570-572
        • Lai C.Q.
        • Tai E.S.
        • Tan C.E.
        • et al.
        The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore.
        J Lipid Res. 2003; 44: 2365-2373
        • Aouizerat B.E.
        • Kulkarni M.
        • Heilbron D.
        • et al.
        Genetic analysis of a polymorphism in the human apoA–V gene: effect on plasma lipids.
        J Lipid Res. 2003; 44: 1167-1173
        • Evans D.
        • Buchwald A.
        • Beil F.U.
        The single nucleotide polymorphism −1131T → C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia.
        J Mol Med. 2003; 81: 645-654
        • Li G.P.
        • Wang J.Y.
        • Yan S.K.
        • et al.
        Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population.
        Clin Genet. 2004; 65: 470-476
        • Bi N.
        • Yan S.K.
        • Li G.P.
        • Yin Z.N.
        • Chen B.S.
        A single nucleotide polymorphism −1131T → C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese.
        Mol Genet Metab. 2004; 83: 280-286
        • Szalai C.
        • Keszei M.
        • Duba J.
        • et al.
        Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.
        Atherosclerosis. 2004; 173: 109-114
        • Hsu L.A.
        • Ko Y.L.
        • Chang C.J.
        • et al.
        Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan.
        Atherosclerosis. 2006; 185: 143-149
        • Weinberg R.B.
        • Cook V.R.
        • Beckstead J.A.
        • et al.
        Structure and interfacial properties of human apolipoprotein A–V.
        J Biol Chem. 2003; 278: 34438-34444
        • Fruchart-Najib J.
        • Bauge E.
        • Niculescu L.S.
        • et al.
        Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5.
        Biochem Biophys Res Commun. 2004; 319: 397-404
        • Prieur X.
        • Coste H.
        • Rodriguez J.C.
        The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-α and contains a novel farnesoid X-activated receptor response element.
        J Biol Chem. 2003; 278: 25468-25480